Tower Research Capital LLC (Trc) Annexon, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Annexon, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,104 shares of ANNX stock, worth $63,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,104

Previous 24,892 4.87%

Holding current value

$63,693

Previous $127,000 60.63%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.93 - $5.5 $2,339 - $6,666	1,212 Added 4.87%	26,104 $50,000
Q4 2024 Feb 13, 2025	BUY	$4.44 - $7.63 $85,696 - $147,266	19,301 Added 345.22%	24,892 $127,000
Q3 2024 Nov 14, 2024	SELL	$4.49 - $7.2 $46,202 - $74,088	-10,290 Reduced 64.79%	5,591 $33,000
Q2 2024 Aug 13, 2024	BUY	$4.33 - $6.79 $38,394 - $60,206	8,867 Added 126.42%	15,881 $77,000
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $19,787 - $38,347	-4,910 Reduced 41.18%	7,014 $50,000
Q4 2023 Feb 13, 2024	BUY	$1.63 - $4.63 $6,749 - $19,172	4,141 Added 53.21%	11,924 $54,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $8,360 - $15,072	3,925 Added 101.74%	7,783 $18,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $6.37 $8,681 - $26,333	-4,134 Reduced 51.73%	3,858 $13,000
Q1 2023 May 09, 2023	BUY	$3.74 - $7.46 $7,117 - $14,196	1,903 Added 31.25%	7,992 $31,000
Q4 2022 Feb 10, 2023	SELL	$4.56 - $6.61 $10,652 - $15,440	-2,336 Reduced 27.73%	6,089 $31,000
Q3 2022 Nov 10, 2022	BUY	$3.75 - $6.63 $6,645 - $11,748	1,772 Added 26.63%	8,425 $52,000
Q2 2022 Aug 15, 2022	BUY	$2.11 - $4.06 $94 - $182	45 Added 0.68%	6,653 $25,000
Q1 2022 May 12, 2022	BUY	$2.73 - $11.94 $7,518 - $32,882	2,754 Added 71.46%	6,608 $18,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $31,000 - $59,356	2,698 Added 233.39%	3,854 $44,000
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $12,524 - $17,924	-766 Reduced 39.85%	1,156 $22,000
Q2 2021 Aug 16, 2021	BUY	$17.81 - $27.48 $9,813 - $15,141	551 Added 40.19%	1,922 $43,000
Q1 2021 May 17, 2021	BUY	$22.0 - $35.01 $15,840 - $25,207	720 Added 110.6%	1,371 $38,000
Q4 2020 Feb 16, 2021	SELL	$20.81 - $30.55 $37,978 - $55,753	-1,825 Reduced 73.71%	651 $16,000
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $43,330 - $74,849	2,476 New	2,476 $75,000

Others Institutions Holding ANNX

# of Institutions

147

Shares Held

96.6M

Call Options Held

36.9K

Put Options Held

83K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $116M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Annexon, Inc. Transaction History